Lauric acid with or without levodopa ameliorates Parkinsonism in genetically modified model of Drosophila melanogaster via the oxidative–inflammatory–apoptotic pathway
Brain and Behavior · 2024
DOI: 10.1002/brb3.70001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain and Behavior, 2024. Verfasst von Olumayowa K Idowu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy, College of Medicine, University of Lagos, Lagos, Nigeria. Hauptthemen laut MEDLINE: Drosophila melanogaster, Lauric Acids, Parkinsonian Disorders, Levodopa. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Parkinson's disease (PD), the most prevalent type of Parkinsonism, is a progressive neurological condition characterized by a range of motor and non‐motor symptoms. The complicated etiology of PD is thought to involve a summation of aging, genetic predisposition, and environmental variables. However, the α‐synuclein protein plays a significant role in the disease's pathophysiology. Materials and methods The UAS‐α‐Syn and Ddc‐Gal4 strains were crossed to produce offspring referred to as PD flies. The entire population of flies was divided into five groups, each having about 100 flies and five replicates. The control group (w 1118 ) and the PD group not receiving treatment were exposed to lauric acid (LA)/levodopa (LD)‐free diet, while the PD groups that received treatments were fed with either a 250 mg/kg LA diet, a 250 mg/kg LD diet, or a combination of the two for 21 days. Longevity, geotaxis, and olfactory assays were performed in addition to other biochemical tests.
Results
As a result of the overexpression of α‐synuclein, the locomotive capacity, lifespan, and antioxidant status were all significantly ( p < .05) reduced, and the apoptotic and neuroinflammatory activities were increased. Nevertheless, the majority of the treated flies improved significantly ( p < .05).
Conclusion
LA, whether combined with LD or not, elicited a significant response in α‐synuclein/dopa decarboxylase genetically modified Drosophila melanogaster Parkinsonism models.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anatomy, College of Medicine, University of Lagos, Lagos, Nigeria.
- Department of Anatomy, College of Health Sciences, Osun State University, Osogbo, Nigeria.
- Department of Anatomy, College of Health Sciences, Federal University of Technology, Akure, Nigeria.
- Department of Human Anatomy, School of Medicine and Pharmacy, College of Medicine and Health Sciences, University of Rwanda, Butare, Rwanda.
ORCID-Profile: Olumayowa K Idowu, Abdullahi A Mohammed
Zitieren
APA
Idowu, O. K., Dosumu, O. O., Boboye, A. S., Oremosu, A. A., & Mohammed, A. A. (2024). Lauric acid with or without levodopa ameliorates Parkinsonism in genetically modified model of Drosophila melanogaster via the oxidative–inflammatory–apoptotic pathway. Brain and Behavior. https://doi.org/10.1002/brb3.70001
Vancouver
Idowu OK, Dosumu OO, Boboye AS, Oremosu AA, Mohammed AA. Lauric acid with or without levodopa ameliorates Parkinsonism in genetically modified model of Drosophila melanogaster via the oxidative–inflammatory–apoptotic pathway. Brain and Behavior. 2024. doi:10.1002/brb3.70001
BibTeX
@article{Idowu2024,
author = {Idowu, Olumayowa K and Dosumu, Olufunke O and Boboye, Ayodeji S and Oremosu, Ademola A and Mohammed, Abdullahi A},
title = {Lauric acid with or without levodopa ameliorates Parkinsonism in genetically modified model of Drosophila melanogaster via the oxidative–inflammatory–apoptotic pathway},
journal = {Brain and Behavior},
year = {2024},
doi = {10.1002/brb3.70001}
}
EUVIMED